SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-006971
Filing Date
2024-01-26
Accepted
2024-01-26 16:05:57
Documents
4
Period of Report
2024-03-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea192072-def14a_citiuspharma.htm DEF 14A 346066
2 GRAPHIC image_001.jpg GRAPHIC 24106
3 GRAPHIC image_002.jpg GRAPHIC 509276
4 GRAPHIC image_003.jpg GRAPHIC 369318
  Complete submission text file 0001213900-24-006971.txt   1590757
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38174 | Film No.: 24567757
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)